GDC-0980 (Apitolisib)

GDC-0980 is an oral PI3 kinase/mTOR dual inhibitor that targets PI3K and mammalian mTOR kinase in the PI3K/mTOR signaling pathway and has potential anti-tumor activity.
Supplier Alfa Cytology
Product # BC0147
Pricing 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback